NeuroPace, Inc. NPCE · SEC Filings

220

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS ...

Price13.12

Market Cap450.33 M

Float25.57 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NeuroPace, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2026

Aug 11, 2026

8-K

NeuroPace Receives FDA "Not Approvable" Letter for RNS System Indication Expansion

Jul 28, 2026

8-K

NeuroPace, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 8, 2026

8-K

NeuroPace, Inc. Announces Financial Results for the First Quarter Ended March 31, 2026

May 12, 2026

8-K

NeuroPace Reports Q4 and Full Year 2025 Results, Reiterates 2026 Outlook Excluding DIXI Medical

Mar 3, 2026

8-K

NeuroPace Q3 2025 Revenue Rises; 2025 Guidance Raised; NAUTILUS PMA-S Submission Targeted for Year-End

Nov 4, 2025

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 18, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 14, 2025

424B4

Common Stock Valuation and Stock-Based Compensation-

Apr 23, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 3, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 4, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2024

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 8, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 2, 2023

S-3

SHELF | ATM | Offering amount: $150,000,000.00 EFFECTIVE

Nov 8, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 21, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 21, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 22, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 22, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 22, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 22, 2024

Ownerships

TYPE

HEADLINE

FILED AT

4

Morrell Martha (Reporting)

Sep 25, 2026

4

Williams Patrick F. (Reporting)

Sep 21, 2026

4

Becker Joel (Reporting)

Sep 4, 2026

SCHEDULE 13G/A

First Light Asset Management, LLC (Filed by)

Sep 4, 2026

4

Becker Joel (Reporting)

Aug 28, 2026

4

Morrell Martha (Reporting)

Aug 28, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 23, 2022

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 22, 2021

CORRESP

Form CORRESP - Correspondence

Apr 21, 2021

CORRESP

Form CORRESP - Correspondence

Apr 21, 2021

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 21, 2021

CORRESP

Form CORRESP - Correspondence

Apr 16, 2021